MERIDIAN BIOSCIENCE, INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2010-11-12: Form 8-K; Period of report 2010-11-11; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2010-10-05: Form 8-K; Period of report 2010-09-30; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2010-09-23: Form 8-K; Period of report 2010-09-17; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2010-07-23: Form 8-K; Period of report 2010-07-20; Description 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 2.02 Results of Operations and Financial Condition; Details 1.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2010-11-12 | 8-K | 2010-11-11 | 2.02 Results of Operations and Financial Condition | 2.02 On November 11, 2010, the Company issued a press release announcing its financial results for the fiscal quarter ended September 30, 2010. | form8k111110.htm |
| 2010-10-05 | 8-K | 2010-09-30 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 (e) On November 12, 2009, the Compensation Committee of the Board of Directors of Meridian Bioscience, Inc. (the “Company”) awarded restricted shares to the Company’s management group under the 2004 Equity Compensation Plan that were subject to the attainment by the Company of a Net Earnings target for fiscal 2010. | form8k093010.htm |
| 2010-09-23 | 8-K | 2010-09-17 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 (b) On September 17, 2010 James A. Buzard, who is age 82 and resides in Lake Forest Illinois, informed Meridian Bioscience, Inc. Executive Chairman, William J. Motto, of his plans to retire from the Board at the end of his term in January 2011. | form8k091710.htm |
| 2010-07-23 | 8-K | 2010-07-20 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 2.02 Results of Operations and Financial Condition | 1.01 Entry into a Material Definitive Agreement. 2.01 The information set forth in Item 1.01 is incorporated herein by reference. 2.02 On July 20, 2010, the Company issued a press release announcing its financial results for the fiscal quarter ended June 30, 2010 (the “Financial Results”). | form8k072010.htm |
| 2010-04-21 | 8-K | 2010-04-20 | 2.02 Results of Operations and Financial Condition | 2.02 On April 20, 2010, the Registrant issued a press release announcing announcing its financial results for the fiscal quarter ended March 31, 2010. | form8k042010.htm |
| 2010-03-23 | 8-K | 2010-03-23 | 7.01 Regulation FD Disclosure | 7.01 A representative from Meridian Bioscience, Inc. (the “Company” or “Registrant”) is providing a presentation at the Sidoti & Company, LLC Fourteenth Annual New York Growth Institutional Investor Forum in New York, New York on March 24, 2010. | c98174e8vk.htm |
| 2010-01-22 | 8-K | 2010-01-21 | 2.02 Results of Operations and Financial Condition | 2.02 On January 21, 2010, the Registrant issued a press release announcing announcing its financial results for the fiscal quarter ended December 31, 2009. | form8k012110.htm |
| 2010-01-14 | 8-K | 2010-01-14 | 7.01 Regulation FD Disclosure | 7.01 A representative from Meridian Bioscience, Inc. (the “Company” or “Registrant”) is providing a presentation at the CJS Securities, Inc. 10th Annual “New Ideas for the New Year” Investor Conference in New York, New York on January 14, 2010. | c94597e8vk.htm |